Pre-Injection Diode Laser Halves Articaine Dose: New RCT - EBIKO Dental Blog

A randomized clinical trial in the November 2026 issue of the Journal of Endodontics reports that irradiating the injection site with a high-power diode laser before injecting let clinicians use half the control group's articaine volume (0.9 mL vs 1.8 mL) in teeth with symptomatic irreversible pulpitis. The laser group reached 100% anesthetic success versus 76.7% in the full-dose control group, with lower pain scores at every stage. It is a single 60-patient trial, so treat it as a promising signal, not a new standard of care.

Profound pulpal anesthesia in a "hot" mandibular molar is one of the most familiar frustrations in endodontics. As of November 2026, a new trial led by a Brazilian research team adds a twist to the usual answers of more volume, supplemental injections or different agents: prepare the tissue with light before the needle goes in. Here is what the study did, what it found, and what it does and does not tell a general dentist or endodontist practising in Toronto, the GTA or anywhere else in Canada.

What Did the Study Test?

The paper, "Efficacy of Preoperative High-Power Diode Laser Irradiation in Reducing Local Anesthetic Volume: A Randomized Clinical Trial," was published online on November 10, 2026 in the Journal of Endodontics (November 2026 issue). The lead author is R.T. Leonardi and the senior author is L.T.A. Cintra; the first author is affiliated with Araraquara Dental School and the senior author with Araçatuba Dental School, both part of Universidade Estadual Paulista (UNESP) in Brazil, with co-authors from other institutions.

According to the abstract, the investigators enrolled 60 patients (ASA I–II, aged 18 to 60) diagnosed with symptomatic irreversible pulpitis in mandibular posterior teeth and randomly allocated them into two groups of 30:

  • Control group: 1.8 mL of 4% articaine with epinephrine.
  • Experimental group: high-power diode laser (HPDL) irradiation at 810 nm and 1.2 W, applied at the puncture site before administering 0.9 mL of the anesthetic.

The primary outcomes were anesthetic success rate and onset latency. Pain was scored on a 0–10 visual analogue scale (VAS) at three moments: needle insertion, coronal access and instrumentation.

What Were the Results?

The abstract reports a clear separation between groups:

  • Anesthetic success: 100% in the laser group, with no patient needing supplemental anesthesia, versus 76.7% in the control group, where 23.3% needed supplemental anesthesia (P < .05).
  • Pain at needle insertion: mean VAS 2.33 with the laser versus 4.27 in the control group.
  • Pain during coronal access: 1.50 versus 2.74.
  • Pain during instrumentation: 0.20 versus 1.56.
  • Speed of onset: profound anesthesia within three minutes in 60% of laser patients compared with 40% of controls.
Mean pain (VAS 0–10) reported in the trial abstract Control: 1.8 mL articaine Laser + 0.9 mL articaine 4.27 2.33 Needle insertion 2.74 1.50 Coronal access 1.56 0.20 Instrumentation Source: Leonardi et al., J Endod, November 2026 (abstract). n = 30 per group.
In the trial, the laser group reported lower mean pain at every stage despite receiving half the anesthetic volume.

The authors conclude that preoperative HPDL irradiation "effectively halves" the anesthetic volume needed while maintaining full clinical efficacy and better patient comfort. That wording is theirs, and it is worth reading precisely: the 0.9 mL dose was fixed by the study design for the laser group, so, as described in the abstract, the trial compares a half dose plus laser with a full dose without laser. It does not report testing other volumes to find a minimum effective dose.

Why Does This Matter for Canadian Practices?

Getting reliable anesthesia in mandibular posterior teeth with symptomatic irreversible pulpitis is a challenge most clinicians recognize from their own chairs. If the result holds up, two practical benefits stand out:

  • Fewer top-ups mid-procedure. In this trial, nearly one in four control patients needed supplemental anesthesia; none in the laser group did. Fewer interruptions mean a calmer patient and a more predictable chair schedule.
  • Lower anesthetic load. A smaller cartridge volume per tooth could matter for patients where clinicians already think carefully about total dose, and for long sessions with multiple procedures.

Pain at the needle itself was also almost half as high in the laser group on the VAS. For many anxious patients the injection is the part they worry about most, so this may be the result they would notice first.

What Are the Limits of the Evidence?

Read this as one well-defined trial, not a settled protocol. Several cautions follow directly from what the abstract does and does not report:

  • Small sample. Sixty patients is a modest base for changing practice. Replication with other operators and other patient populations is the obvious next step.
  • Narrow indication. The trial covered mandibular posterior teeth with symptomatic irreversible pulpitis. The findings cannot be assumed to transfer to maxillary infiltrations, healthy pulps, children or surgical procedures.
  • One laser setting. Only an 810 nm diode at 1.2 W was tested. Other wavelengths, powers or exposure times were not studied, so results should not be generalized to any laser in the operatory.
  • Abstract-level reading. The full text is not open access, and this summary is based on the published abstract. Details such as blinding, the exact injection technique and how success was defined are not described in the abstract, and they matter when judging the strength of the result.

Pro Tip: Before trialling any new pre-injection protocol, read the full methods section of the paper (through a university library or professional association access, where available) and document your own outcomes for at least 20 consecutive cases so you are judging the technique on your own patients, not just one study's.

What Should Dentists in Ontario Do Now?

Nothing in this study changes current anesthetic standards on its own. For practices in Toronto, Mississauga, Markham and beyond that already own a diode laser for soft-tissue work, the paper is a reason to watch for confirmatory trials and, for interested clinicians, to look closely at the protocol. For practices without a laser, it is not, by itself, a reason to buy one.

Any laser use sits inside your professional obligations: training on the specific device, the manufacturer's instructions for use, eye protection for everyone in the operatory and informed consent when a technique is new to your practice. Confirm the Health Canada medical device licence status of any laser before purchasing it, and check guidance from the Royal College of Dental Surgeons of Ontario (RCDSO) on adopting new techniques within your scope of practice.

Pro Tip: If you add any pre-injection step, record it in the chart the same way you record the anesthetic itself: agent, volume, technique and, for a laser, the device, wavelength and power used. A clean record protects you and makes your own outcome review possible.

EBIKO Dental will continue monitoring endodontic anesthesia research and will report on replication studies as they are published. For dental supplies shipped across Canada, visit ebiko.ca.

Sources

  • Leonardi RT, Berbert FLCV, Aranda J, et al., Cintra LTA. Efficacy of Preoperative High-Power Diode Laser Irradiation in Reducing Local Anesthetic Volume: A Randomized Clinical Trial. J Endod. November 2026. doi:10.1016/j.joen.2026.11.001 (record: Europe PMC)

Frequently Asked Questions

Q: Can a diode laser reduce how much local anesthetic a root canal patient needs?

One November 2026 randomized trial in the Journal of Endodontics found that 810 nm diode laser irradiation at the injection site, followed by 0.9 mL of 4% articaine, achieved 100% anesthetic success in 30 patients with symptomatic irreversible pulpitis in mandibular posterior teeth, versus 76.7% with 1.8 mL and no laser. It is a single small study, so confirmation is needed before it changes practice.

Q: Did the laser make the injection itself less painful?

Yes, in that trial. Mean pain at needle insertion was 2.33 out of 10 in the laser group versus 4.27 in the control group, and pain was also lower during access and instrumentation.

Q: Should my practice start using a laser before injections?

Not on the strength of one trial. Review the full paper, wait for replication, and make sure any device is licensed by Health Canada and used within your training and the RCDSO's expectations for your scope of practice.

Dental-industry-trends, Endodontics, Practice-owners

Leave a comment

All comments are moderated before being published